• Ginsenoside F1 and HepG2 Lipid Metabolism: Lipidomics

  2026-08-23

  The reference study combines an FFA-induced HepG2 model with untargeted lipidomics to show that ginsenoside F1 reduces intracellular lipid deposition, cholesterol, and triglycerides. Its main contribution is linking these phenotypic effects to changes in glycerophospholipid and ether lipid metabolism, while network pharmacology and docking provide hypotheses for targets such as Akt1, PPARG, and EGFR.

• Talabostat Mesylate: From DPP4 to Translational Design

  2026-08-22

  Talabostat mesylate, also known as PT-100 or Val-boroPro, offers translational researchers a way to connect DPP4 and FAP inhibition with immune, stromal, and hematopoietic readouts. This thought-leadership perspective explains how to design rigorous studies around target engagement, tumor-context biology, and the selectivity lessons emerging from DPP9 inflammasome research.

• Nonselective β-Blockers and Hematopoietic Recovery

  2026-08-22

  The reference study identifies a context-dependent effect of nonselective β-adrenergic blockade on hematopoietic regeneration after transplantation. By combining mouse transplant models with human allogeneic HCT data, it distinguishes carvedilol-associated impairment from the comparatively limited effect of β1-selective metoprolol and highlights transplant cell dose and GVHD prophylaxis as important modifiers.

• BicD and MAP7 Activate Drosophila Kinesin-1

  2026-08-21

  This preprint shows that BicD and MAP7 activate homodimeric Drosophila kinesin-1 through complementary mechanisms: BicD relieves motor autoinhibition, whereas MAP7 improves microtubule engagement and run length. The work provides a mechanistic framework for understanding how adaptor proteins and microtubule-associated proteins jointly regulate bidirectional cargo transport.

• Cy7 NHS Ester: Practical Labeling Workflow

  2026-08-20

  Cy7 NHS ester (SKU A8109) is a water-soluble, sulfonated near-infrared dye for labeling accessible amino groups on proteins, peptides, and related biomolecules. It is suited to near-infrared fluorescent imaging and live-cell or in vivo tracking workflows, but not to experiments requiring long-term storage of prepared dye solutions or detection systems that cannot support its near-infrared wavelengths.

• Biotin (Vitamin B7, Vitamin H) in Cell Assays

  2026-08-20

  A scenario-based guide to using Biotin (Vitamin B7, Vitamin H), SKU A8010, in viability, proliferation, cytotoxicity, and protein-labeling workflows. It emphasizes solvent compatibility, metabolic interpretation, assay controls, and practical vendor selection without overstating what free biotin can achieve.

• (1S,3R)-RSL3 Glutathione Peroxidase 4 Inhibitor

  2026-08-19

  Build reproducible ferroptosis assays with RSL3 by combining GPX4 inhibition, lipid-peroxidation readouts, and mechanism-specific rescue controls. The workflow also helps distinguish ferroptotic killing from the apoptosis-linked RNA Pol II response described in recent Cell research.

• HyperPFU™ High-Fidelity DNA Polymerase Guide

  2026-08-19

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is suitable for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or sticky-end generation.

• G-1: Designing Selective GPR30 Signaling Assays

  2026-08-18

  G-1 is a selective GPR30 agonist for separating rapid GPER1 signaling from classical estrogen-receptor activity. This guide translates mechanistic evidence into practical assay design for immune, cardiovascular, and cancer research.

• GlycoRNA–csRBP Domains Guide TAT Entry

  2026-08-18

  This preprint expands the concept of the cell surface by identifying organized domains containing glycoRNAs and cell-surface RNA-binding proteins. Its perturbation experiments connect these domains to TAT cell entry, suggesting that extracellular RNA–protein organization can regulate communication with cell-penetrating peptides.

• JHU-083 and the Logic of Glutaminase Assays

  2026-08-17

  JHU-083 is a 6-diazo-5-oxo-L-norleucine precursor that enables causal interrogation of glutaminase activity in cerebral immune-cell models. This article develops an assay-centered framework connecting glutamate measurements, redox biology, and the limitations of translating hepatotoxicity findings into neurological research.

• E-64 as a Lysoptosis Assay Probe

  2026-08-17

  E-64 provides a covalent, irreversible approach to cysteine protease inhibition and a practical way to test cathepsin-dependent lysosomal cell death. This article connects its biochemical selectivity with lysoptosis assay design, helping researchers distinguish lysosomal membrane damage from downstream proteolytic execution.

• GlycoRNA–RBP Nanodomains Enable TAT Entry

  2026-08-16

  This preprint proposes that cell-surface RNA-binding proteins and glycoRNAs assemble into nanoclusters that function as interaction sites for the cell-penetrating peptide TAT. Its perturbation experiments connect extracellular RNA organization with peptide internalization, broadening the functional definition of the plasma membrane beyond conventional transmembrane and lipid-anchored proteins.

• Acridine Orange hydrochloride Protocol Guide

  2026-08-15

  Acridine Orange hydrochloride provides a practical fluorescence-based approach for distinguishing nucleic-acid-associated green and red signals in cells and organelles. This dossier-grounded guide supports assay planning and QC, but it does not establish a universal staining concentration, incubation time, apoptosis diagnosis, or clinical application.

• ML133 HCl for Kir2.1 Research

  2026-08-14

  ML133 HCl is a selective potassium channel inhibitor for isolating Kir2.1-dependent effects in pulmonary vascular and cardiovascular ion channel research. This workflow translates published PASMC findings into practical dose design, migration assays, pathway validation, and troubleshooting steps.

8396 records 1/560 page Next 12345 下5页 Last page